© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Methylsynephrine didn’t just show up in the world of science labs and supplement bottles out of nowhere. Tracing back to its roots, researchers started poking around with phenylethylamine derivatives over a century ago, hoping to unlock new stimulants and bronchodilators. Early studies on symathomimetic amines opened the door for methylsynephrine, which chemists synthesized while hunting for alternatives to ephedrine. Through the decades, it caught the eyes of scientists for its close relationship to naturally occurring synephrine found in bitter orange. As industry demand for potent fat-burners and mild stimulants picked up, methylsynephrine’s story unfolded alongside shifts in drug policy, sports regulation, and changing public attitudes toward over-the-counter energy compounds. Even though methylsynephrine never made it onto pharmacy shelves as a major medication, it carved out a niche in supplement formulas thanks to its stimulating effects.
Most folks running into methylsynephrine probably see it listed as an ingredient on dietary supplements, pre-workout blends, or “fat-burning” capsules. This compound is marketed with claims around boosting energy, improving focus, and revving up the metabolism. Digging into any supplement facts label, you’ll notice manufacturers use a number of synonyms, such as Oxilofrine, methyl-synephrine, or p-hydroxyephedrine. The bulk raw ingredient usually appears as a crystalline white powder. Some brands slap bold claims on their products, pushing the promise of quick weight loss or better athletic endurance. In reality, product stability and dosing can vary, and that inconsistency spurred regulatory concern—especially from agencies like the FDA, which flagged certain supplements due to health risks.
Methylsynephrine, chemically known as 4-[1-hydroxy-2-(methylamino)ethyl]phenol, shows up as a fine white powder under normal conditions. Its molecular formula, C9H13NO2, points to a structure sharing many traits with other amphetamine-type compounds. As a phenylethylamine derivative, its backbone is similar to adrenaline and synephrine, setting the stage for its adrenergic effects. The powder dissolves well in water and alcohol, which matters when mixing it into solutions or formulations. A melting point hovering around 188–190°C supports purity checks for raw material. Labs rely on identifying features like infrared spectroscopy or HPLC (high-performance liquid chromatography) results to make sure suppliers aren’t cutting corners on quality.
Technical specifications for methylsynephrine demand tight controls on purity, moisture content, and potential contaminants. Any batch moving through a reputable supply chain should clock in above 98% purity, with limits on heavy metals, microbials, and related compounds. Certificates of analysis expected by responsible manufacturers back up these numbers, but end users rarely get to see that paperwork. Labeling can get tricky since countries differ in their regulations, with some requiring full disclosure of source, amount, and warnings about stimulant use or cardiovascular impact. The best products don’t hide behind proprietary blends and show exact dosages, although plenty of supplements still skirt these best practices. Label transparency matters because different forms—hydrochloride salt or free base—can seriously affect how the body absorbs and processes methylsynephrine.
Synthesis of methylsynephrine often relies on starting with p-hydroxyphenylacetone or related aromatics, then running through a methylation or aminoethylation reaction. Chemical suppliers and university labs typically use a combination of reduction steps, alkylation, and purification through crystallization. What sounds straightforward on paper hides a real risk: small mistakes in temperature, solvents, or purification can leave behind byproducts or impurities, some of which strain the kidneys and liver if not removed. Reliable manufacturers invest in good clean-room practices, batch record-keeping, and quality control processes that keep health and safety on track. Cutting corners, especially in gray-market supplement production, leaves room for hazardous contamination.
Chemists look for ways to tweak methylsynephrine to fine-tune its action, slow down its breakdown, or improve its safety. They start with its phenolic and amine groups, which can handle further methylation, acylation, or conversion into hydrochloride or sulfate salts. Each modification shifts the way this compound interacts with enzymes like monoamine oxidase or catechol-O-methyltransferase, which means some tweaks can ramp up potency while others slow absorption. Sometimes, researchers attach other small groups to see if the stimulant effect can soften or if side effects can be dialed down. Screening analogues in the lab produces data that shape how future supplements or medications could balance risk and benefit.
A quick look around the supplement or research-chemical marketplace turns up a collection of names for methylsynephrine. Oxilofrine stands out, particularly in anti-doping circles, as it pops up on banned substance lists for athletes. Methylsynephrine is also known as p-hydroxyephedrine, or sometimes by its research code numbers. Labels from less scrupulous companies might use “extract of Citrus aurantium” as a euphemism, which muddles the waters for anyone scanning ingredients lists for safe and legal compounds. The patchwork of synonyms makes it easy for both well-meaning athletes and regular consumers to get tripped up, risking failed drug tests or unknowingly taking potentially risky substances.
Safety guidelines call for strict adherence to good manufacturing practice (GMP) and regular testing of both raw materials and finished products. Facilities handling methylsynephrine keep temperature, humidity, and cross-contamination in check. Worker protection—using gloves, masks, and proper ventilation—matters a great deal, given the risk of inhalation or skin contact with this potent stimulant. On the regulatory end, organizations like the World Anti-Doping Agency (WADA) flag methylsynephrine as a prohibited substance. Several countries, including the U.S., take action against supplements containing it, mainly due to concerns about heart rhythm problems, high blood pressure, and dangerous interactions with other medications. Clear labeling, batch documentation, and comprehensive risk assessments help cut down on accidental exposure or misuse.
Sports and fitness fuel much of methylsynephrine’s demand, as supplement companies chase after the next legal edge in athletic performance and fat loss. Some researchers tested it as a potential treatment for low blood pressure or asthma, hoping to replicate the benefits of earlier adrenergic drugs without as many side effects. Outside medicine, methylsynephrine shows up in pharmacological studies exploring receptor activity, metabolic rates, and how the body clears related compounds. The crossover between scientific interest and consumer demand creates a risky landscape, especially as regulatory gray zones and online marketing muddy the water around safe, legal applications.
Investigators run animal studies and small clinical trials trying to figure out how methylsynephrine stacks up against known stimulants. Teams examine cardiovascular impact, metabolic rate effects, and neurological stimulation, looking for any signs that might suggest value—or danger—for human health. There’s ongoing debate in medical literature about how structurally similar compounds affect different adrenergic receptors. Some research groups are chasing safer analogues that keep a stimulatory kick but lower blood pressure spikes or jittery side effects. Others hunt for data on metabolism and excretion pathways, since the way the liver and kidneys handle methylsynephrine impacts drug interactions and chronic use.
Toxicologists make a point of exposing animal models and human volunteers to varying doses of methylsynephrine to map out the line between usefulness and danger. At lower doses, side effects often look like rapid heart rate, raised blood pressure, headaches, and nausea. With higher doses, the risk of heart rhythm disorders, chest pain, or even seizure becomes much more than a theoretical worry. People taking methylsynephrine alongside caffeine, other stimulants, or prescription meds for weight loss or ADHD risk unpredictable interactions. Despite warnings, supplement brands sometimes brush off these risks downplay real-world cases of hospitalization or harm. Toxicity studies provide the foundation for regulatory action, since clinical evidence, case reports, and postmarketing surveillance data shape public policy and professional guidelines.
The push for safer, more effective metabolic and cognitive enhancers drives some of the ongoing interest in methylsynephrine. As regulatory bodies tighten controls and public awareness of the dangers of untested supplements grows, the compound’s days as a casual ingredient seem numbered. Researchers hope to leverage lessons learned from methylsynephrine’s properties—structural tweaks, animal model results, and population studies—to guide the development of next-generation compounds that can support weight loss or energy without the cardiac risks. At the same time, anti-doping agencies and consumer safety advocates dig in deeper, pushing for stricter transparency and better surveillance over supplement markets. What started as a chemist’s curiosity now sits at the busy intersection of modern science, sports regulation, and health policy, offering both a cautionary tale and a stepping stone for thoughtful innovation.
Methylsynephrine showed up in dietary supplements mostly as a stimulant marketed toward athletes and fitness enthusiasts. Companies pitched it as a fat burner and energy booster, sometimes using alternative names like oxilofrine. Over the years, folks looking for an edge in sports or help with dropping pounds have stumbled onto it in pre-workout powders or weight-loss capsules. The idea makes sense on the surface—get something that cranks up your heart rate and metabolism, and the pounds may start falling off. Real world use tells a more complicated story.
Chemically, methylsynephrine’s related to synephrine and ephedrine, compounds with a mild effect on the central nervous system. It acts as a stimulant, so it can bump up energy levels for a short while and arguably help with focus or motivation in the gym. In some small studies and case reports, methylsynephrine increased blood pressure and heart rate. These claims led some to believe it kickstarts metabolism, but there’s little solid science showing a true benefit for weight loss over the long haul.
I’ve seen people rush out to buy the latest energy pill or fat shredder, just hoping for something that finally works. With methylsynephrine, the tradeoff gets risky. It carries real potential for harm—spiking blood pressure, raising the heart’s workload, even boosting the chance of arrhythmia or serious heart complications. The U.S. Food and Drug Administration (FDA) moved against products containing it, warning companies and consumers that methylsynephrine’s never been approved as a dietary ingredient. Several countries banned it for athletes over concerns about performance enhancement and safety, and the World Anti-Doping Agency (WADA) placed it on its list of prohibited substances. If someone gets tested in competition, even trace amounts could cost their career.
There’s no easy fix for losing weight or hitting a new gym milestone. That’s what draws people toward stimulants like methylsynephrine. Ads emphasize fast results, using phrases that sound convincing to the average workout regular. I’ve watched friends toss down supplement capsules without a full picture of side effects or any clue about what the labels really mean. Slick marketing takes advantage of that desire to make progress fast, especially when progress feels slow. In the end, the promised shortcuts can backfire.
There's real need for honest conversations about what actually works for fitness, whether with a coach, doctor, or experienced friends. If someone wrestles with weight or energy, lifestyle changes—regular movement, meal planning, sleep—bring reliable results over time. Community supports and tailored advice beat chasing secret ingredients. Food and nutrition policy needs strong enforcement, not just on paper, to keep potentially risky compounds like methylsynephrine out of unsuspecting hands. More research into safety and long-term effects could protect athletes and casual gym-goers alike. We all deserve to know what's in our supplements before taking chances on them.
Methylsynephrine goes by a few names, like oxilofrine, and often pops up in dietary supplements promising fat loss, boosted energy, or performance enhancement. The draw comes from its chemical similarity to synephrine, which itself mimics the structure of adrenaline found in the body. I see supplement companies market it as a way to push workouts harder, drop pounds quicker, or feel more alert.
Sometimes, excitement for results drowns out careful reading of research. Real-world studies on methylsynephrine in humans remain extremely limited. Most knowledge comes from case reports or observations of its effects in athletics—especially when athletes failed doping tests because it showed up in their system.
The World Anti-Doping Agency banned oxilofrine in sports. That's because it can stimulate the heart in a way that looks a lot like amphetamine-based substances. People use it hoping for better endurance or fat-burning, but with hardly any controlled research on long-term impact, that’s taking chances with your health.
People sometimes shrug off the idea that a legal supplement can cause real harm. We’ve seen the same thing happen with stimulants like ephedra or DMAA, which got pulled off the market after reports of heart attack and stroke.
A few years back, the FDA sent warning letters to companies selling products labeled "methylsynephrine." Unlike caffeine, this isn’t a compound the human body handles in small quantities every day. You might get headaches, elevated blood pressure, irregular heartbeat, or feelings of anxiety. I’ve talked to fitness coaches and doctors who get stories from people who ended up in urgent care after downing pre-workouts laced with stimulants masquerading as natural ingredients.
Supplement labels aren’t always transparent. Lab tests sometimes show more methylsynephrine in a product than what the label promises—or none at all. No strict oversight exists in the supplement world like in pharmaceutical drug production, so a scoop from one tub might pack a bigger jolt than another, even with the same brand.
The FDA warned consumers that methylsynephrine should not be present in dietary supplements. That’s not just legal red tape. It’s risk, especially if you have an underlying heart issue you may not know about.
People don’t always want to give up the edge that supplements offer. I get that—who doesn’t want better workouts or speedy weight loss? Still, health matters more in the long game. If energy or fat loss is the goal, daily habits trump shortcuts. Checking with a healthcare provider beats relying on a supplement label or anonymous gym advice. Professional input can spot risks before they spiral into emergencies.
I see better results when folks pay attention to sleep, food quality, hydration, and a smart workout plan. No mystery powder will outdo consistency in those basics. Supplements can help fill small gaps, but methylsynephrine brings a long list of questions and very few answers.
Decision-making boils down to risk versus benefit, and for methylsynephrine, the evidence stacks pretty heavy on the risk side. There are plenty of ways to get more energy or shed some weight without rolling the dice on your heart health.
Methylsynephrine pops up in a lot of weight loss and workout supplements, promising energy and faster fat-burning. Many products advertise it as a “safe” alternative to ephedra. Marketing aside, the safety of a stimulant like methylsynephrine needs some attention. I’ve seen people pick up these pills at supplement shops, drawn in by promises, but not everyone checks how the body handles something like this.
Methylsynephrine works by stimulating the central nervous system, raising the heart rate and blood pressure. This boost can feel like more energy at the gym or some sharper focus, but that heightened state carries risks. The heart and blood vessels tend to shoulder the burden, especially in anyone with underlying health conditions—even if those conditions haven’t shown up yet.
From what health data and case reports tell us, methylsynephrine can trigger:
More serious reports tie methylsynephrine to chest pain and, in rare cases, life-threatening heart problems such as arrhythmias and heart attacks. For young, generally healthy people, that risk feels low, but stories of athletes collapsing during training after a dose remind us nobody gets a pass.
It’s easy to grab a supplement from the shelf with the thought that a product in a health food store must be safe. I’ve seen folks add pills like methylsynephrine to their daily routine with little hesitation. FDA warnings have flagged methylsynephrine as unapproved for dietary use in the United States, but online shops still carry it. What worries me is how quickly a push for weight loss or more energy can cloud judgment about possible damage to the heart, especially without regular doctor visits or health checkups.
What the research says lines up with personal stories. A study published in the Journal of Analytical Toxicology found methylsynephrine in supplements at levels higher than declared on the labels, highlighting not only safety questions but also trust issues between consumers and manufacturers. People with high blood pressure, a history of heart problems, or anyone taking medications for these conditions put themselves at extra risk by using these supplements.
Some folks come to rely on shortcuts, hoping a stimulant can unlock faster results. Years working around gyms and health stores taught me patience works better than anything that promises results overnight. Trust in advice from doctors and registered dietitians beats marketing hype. Stepping away from risky products and focusing on lasting lifestyle changes—regular exercise, balanced meals, enough sleep—will always serve better in the long run.
Ask questions about anything in a supplement bottle and check for proof of safety. If in doubt, skip supplements with methylsynephrine altogether. The risk to heart and mental health is too high, especially when safer and more sustainable options stand close by.
Methylsynephrine sounds harmless enough—similar to ingredients often found in energy boosters at the grocery store. A closer look changes things fast. This is a stimulant, once found in certain fitness supplements, often touted for its promises to boost metabolism and fat loss. Yet, the legal standing of methylsynephrine isn’t straightforward.
Walk into any supplement shop and the walls are packed with pills and powders promising athletic gains or quick energy. Many shoppers trust these products to be safe just because they’re available. In reality, regulations depend on enforcement and regular review, and methylsynephrine highlights the gaps. In the United States, the Food and Drug Administration (FDA) flagged methylsynephrine as illegal to add to supplements back in 2016. Official enforcement letters went out to companies selling it, citing its status as a synthetic version of a prescription drug. No grandfather clause kept it on shelves.
Personal experience taught me the lesson after seeing friends bring back bottles from online sources, thinking they were getting an edge. They soon found out some foreign suppliers don’t follow U.S. rules. They ran the risk of ending up with untested, potentially dangerous powders. Getting methylsynephrine by accident felt easier than finding a regulated medication.
Methylsynephrine acts as a stimulant, similar to ephedrine, which the FDA banned from supplements years ago due to reports of heart attacks and strokes. Even small doses speed the heart up, raise blood pressure, and stress the cardiovascular system. Scientific literature connects these compounds to real risks, especially in people who jump on trends without looking into side effects.
The World Anti-Doping Agency (WADA) banned methylsynephrine for athletes competing worldwide. So anyone in professional or amateur sports has real consequences even for accidental use. A positive test can cost years of work and thousands in earnings. I know teammates who nervously sift through ingredient lists before every competition, and stigma lingers long after a failed test—even if it came from a mislabeled supplement.
Banned in the United States, unavailable by prescription, and not supposed to show up at GNC, methylsynephrine still turns up in online sales channels, usually in powder or capsule form. These purchases slide through customs far too easily, often mislabeled. Some online sellers avoid direct claims about what’s inside the bottle, making it even harder to know what’s being ingested. I’ve seen bottles with labeling in multiple languages that never clarify exactly what’s inside.
More education helps, but we need much stricter checks and easier reporting for supplements that break the law. Doctors and coaches should warn clients about searching for shortcuts through unapproved stimulants. If a product sounds too good to be true, it probably is. The promise of easy energy shouldn’t come with a side of heart palpitations.
Stronger penalties for online sellers who sneak banned substances into the country could close open doors. Most consumers want the benefits advertised on packages, not a visit to the ER. Laws already exist, but making them count takes action by more than just regulators—it takes attention from those who make and buy supplements too.
Safe, legal options don’t just follow the law—they give athletes and gym-goers peace of mind.
People hear about methylsynephrine mainly from weight-loss supplements. Some walk into nutrition stores, see bold promises on the label, and think they've found an answer for extra energy or a faster metabolism. It’s an ingredient with a reputation, but that reputation comes at a cost. Methylsynephrine walks a fine line between legal pre-workout ingredient and banned athletic substance. Without much solid human research behind it, most dosing advice comes out of gray areas rather than clear rules.
Methylsynephrine can act as a stimulant, affecting the heart and nervous system. Most suggestions for dosing float online, based on personal testimonials or extrapolated from animal studies, not on thorough clinical trials with long-term data. Doses range anywhere from 10 to 100 milligrams per day in supplement culture. Some talk about splitting doses morning and afternoon, chasing supposed fat-burning effects without a clear idea of what the body can handle. No official agency in the United States, Europe, or Asia has approved a dosing regimen.
Doctors point out how little information exists. The structure of methylsynephrine looks similar to compounds like ephedrine and phenylephrine. Both of those can speed up heart rate, spike blood pressure, and overstimulate. Many who reach for these supplements don’t realize how the heart can react—especially those with undiagnosed medical problems or people mixing other stimulants like caffeine.
Cases pop up every few years of folks landing in the emergency room after downing a supplement laced with methylsynephrine. Heart palpitations, anxiety, and shaky hands tell part of the story, but things sometimes head in a much darker direction. The World Anti-Doping Agency (WADA) flagged methylsynephrine years ago, and for good reason. Athletes using it run the risk of testing positive, facing suspensions or bans. But those outside the competitive arena deal with their own risks: arrhythmias, dangerously high blood pressure, and strokes.
Reading about these incidents in medical journals and news reports, one thing jumps out: most people had no clue what dose worked, or even what they were taking. Supplement labels don’t always tell the truth. Independent tests have shown wild discrepancies between what’s promised and what’s actually inside the bottle.
Sticking to facts matters. Until real human trials carve out a safer path, advice on methylsynephrine stays murky. Retailers and gyms rarely tell customers that long-term heart problems could follow regular use. The supplement industry in the US often flies under the radar, with weak FDA oversight. Most doctors urge people to skip unregulated stimulants—especially those with blood pressure or heart history.
One solution emerges: better-informed choices. More transparent labeling, independent chemical analysis, and zero tolerance for wild claims would give consumers a fighting chance. Bodies like the FDA, Consumer Reports, and the US Anti-Doping Agency already warn about methylsynephrine. Consumers who dig into those warnings, or bring concerns to pharmacists and knowledgeable doctors, end up safer in the long run.
My years working around athletics and fitness reveal a blunt truth: a quick boost rarely pays off when the long-term risks weigh so heavy. Anyone considering a stimulant, especially one surrounded by controversy, owes it to themselves to research hard, question the source, and ask what’s really inside that capsule. Until the science catches up and laws change, taking methylsynephrine is a roll of the dice.
| Names | |
| Preferred IUPAC name | 4-(1-Hydroxy-2-methylaminoethyl)phenol |
| Other names |
Oxilofrine p-Hydroxyephedrine 4-Hydroxyephredrine methylphrine |
| Pronunciation | /ˌmɛθ.ɪl.sɪnˈɛf.rɪn/ |
| Identifiers | |
| CAS Number | 94-07-5 |
| Beilstein Reference | 1209281 |
| ChEBI | CHEBI:9515 |
| ChEMBL | CHEMBL2104747 |
| ChemSpider | 215521 |
| DrugBank | DB08963 |
| ECHA InfoCard | echa.europa.eu/substance-information/-/substanceinfo/100.209.249 |
| EC Number | EC 3.1.1.73 |
| Gmelin Reference | 1517809 |
| KEGG | C15992 |
| MeSH | D02BB04 |
| PubChem CID | 72278 |
| RTECS number | KW2975000 |
| UNII | Y6V2W302FA |
| UN number | UN3435 |
| Properties | |
| Chemical formula | C10H15NO |
| Molar mass | 225.294 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 0.936 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -0.52 |
| Vapor pressure | 1.99E-4 mmHg at 25°C |
| Acidity (pKa) | 9.43 |
| Basicity (pKb) | 9.03 |
| Magnetic susceptibility (χ) | -68.0×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.558 |
| Dipole moment | 2.59 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 321.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | −269.3 kJ/mol |
| Pharmacology | |
| ATC code | R03CA08 |
| Hazards | |
| Main hazards | May cause cardiovascular effects, increased blood pressure, and central nervous system stimulation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | DANGER |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-3-2-0 |
| Flash point | 116.8°C |
| Autoignition temperature | Autoignition temperature: 500°C |
| Lethal dose or concentration | LD50 (oral, rat): 350 mg/kg |
| LD50 (median dose) | LD50 (median dose): 350 mg/kg (oral, rat) |
| NIOSH | RN: 94-07-5 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | Not recommended |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Synephrine Octopamine Phenylephrine Ephedrine p-Hydroxyamphetamine N-Methyltyramine |
